These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9040744)

  • 41. Characterization of a Portuguese family with Charcot-Marie-Tooth disease type 1E due to a novel point mutation in the PMP22 gene.
    Fernandes M; Caetano A; Castelhano L; Santos L
    Clin Neurol Neurosurg; 2021 Sep; 208():106829. PubMed ID: 34332267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.
    Nobbio L; Visigalli D; Radice D; Fiorina E; Solari A; Lauria G; Reilly MM; Santoro L; Schenone A; Pareyson D;
    Brain; 2014 Jun; 137(Pt 6):1614-20. PubMed ID: 24812204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic testing practices for Charcot-Marie-Tooth type 1A disease.
    Tousignant R; Trepanier A; Shy ME; Siskind CE
    Muscle Nerve; 2014 Apr; 49(4):478-82. PubMed ID: 23963961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased severity over generations of Charcot-Marie-Tooth disease type 1A.
    Steiner I; Gotkine M; Steiner-Birmanns B; Biran I; Silverstein S; Abeliovich D; Argov Z; Wirguin I
    J Neurol; 2008 Jun; 255(6):813-9. PubMed ID: 18438698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A case of hereditary motor and sensory neuropathy type I with a new type of peripheral myelin protein (PMP)-22 mutation].
    Ohnishi A; Yoshimura T; Kanehisa Y; Fukushima Y
    Rinsho Shinkeigaku; 1995 Jul; 35(7):788-92. PubMed ID: 8777804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation of the myelin P0 gene in Charcot-Marie-tooth neuropathy type 1.
    Hayasaka K; Ohnishi A; Takada G; Fukushima Y; Murai Y
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1317-22. PubMed ID: 7688964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic basis of inherited peripheral neuropathies.
    Suter U; Patel PI
    Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity.
    Lupski JR
    Pediatr Res; 1999 Feb; 45(2):159-65. PubMed ID: 10022584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
    Young P; Stögbauer F; Wiebusch H; Löfgren A; Timmerman V; Van Broeckhoven C; Ringelstein EB; Assmann G; Funke H
    Neurology; 1998 Mar; 50(3):760-3. PubMed ID: 9521270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
    Numakura C; Lin C; Ikegami T; Guldberg P; Hayasaka K
    Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S; Young P; Suter U
    Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Charcot-Marie-Tooth disease type 1A: mutational mechanisms and candidate gene.
    Patel PI
    Curr Opin Genet Dev; 1993 Jun; 3(3):438-44. PubMed ID: 8353419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations.
    Gabreëls-Festen AA; Bolhuis PA; Hoogendijk JE; Valentijn LJ; Eshuis EJ; Gabreëls FJ
    Acta Neuropathol; 1995; 90(6):645-9. PubMed ID: 8615087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B.
    Kulkens T; Bolhuis PA; Wolterman RA; Kemp S; te Nijenhuis S; Valentijn LJ; Hensels GW; Jennekens FG; de Visser M; Hoogendijk JE
    Nat Genet; 1993 Sep; 5(1):35-9. PubMed ID: 7693130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
    Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
    J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
    Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
    J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
    Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
    Brancolini C; Edomi P; Marzinotto S; Schneider C
    Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid detection of duplication/deletion of the PMP22 gene in patients with Charcot-Marie-Tooth disease Type 1A and hereditary neuropathy with liability to pressure palsy by real-time quantitative PCR using SYBR Green I dye.
    Kim SW; Lee KS; Jin HS; Lee TM; Koo SK; Lee YJ; Jung SC
    J Korean Med Sci; 2003 Oct; 18(5):727-32. PubMed ID: 14555828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequence of human GAS3/PMP22 full-length cDNA.
    Edomi P; Martinotti A; Colombo MP; Schneider C
    Gene; 1993 Apr; 126(2):289-90. PubMed ID: 8482547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.